Botulinum toxin-A (BoNT-A) has been increasingly used in the cosmetic dermatology daily routine since the 1980s. Three formulations of BoNT-A are marketed in the USA; these are onabotulinum toxin-A (trade name: Botox), abobotulinum toxin-A (trade name: Dysport), and incobotulinum toxin-A (trade name: Xeomin). The dilution of the formulations differ; however, the injection points and outcomes are